The Challenges of Developing Drugs for NASH Cirrhosis: The Example of Belapectin
Time: 2:00 pm
day: Day 1 Stream 1 PM
Details:
- Addressing cirrhosis in patients with clinical signs of portal hypertension
- Interrogating therapeutic efficacy and expanding the scope of target patient populations
- Innovating clinical trial design with adaptive design to determine dose and better understand efficacy
